Home Tags Pembrolizumab

Tag: pembrolizumab

Combination Enfortumab Vedotin + Pembrolizumab Granted Breakthrough Therapy in Bladder Cancer

Peter Hofland, Ph.D -

Enfortumab Vedotin + Pembrolizumab Shrink Tumors in the Majority of Bladder...

Peter Hofland, Ph.D -
Doctor discussing treatment options with a patient.

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

Andrea Maddox-Smith -

Enfortumab Vedotin + Pembrolizumab to be Evaluated in Metastatic Bladder Cancer

Peter Hofland, Ph.D -
Glioblastoma with extreme nuclear enlargement.

Tasadenoturev + Pembrolizumab Shows Clinical Benefit in Recurrent Glioblastoma

Peter Hofland, Ph.D -
Woman with lung cancer during medical visit

WCLC 2019: Updates from the Pembrolizumab Clinical Development Program

Peter Hofland, Ph.D -
Human kidney cross section. Photo courtesy: 2019 Fotolia

Europe Adopts Pembrolizumab + Axitinib as First-Line Treatment for Advanced Renal...

Peter Hofland, Ph.D -

Pembrolizumab + Chemotherapy meets Primary Endpoint in Pivotal Phase III Trial...

Peter Hofland, Ph.D -
Low magnification micrograph of hepatocellular carcinoma the most common form of primary liver cancer. Features on image: End-stage cirrhosis - blue collagen (fibrosis); Mallory bodies; Loss of normal liver architecture; Nuclear atypia.

Breakthrough Therapy Designation for Pembrolizumab + Lenvatinib in Hepatocellular Carcinoma

Peter Hofland, Ph.D -
Merck | MSD Exhibition booth at the 2019 annual meeting of the American Society of Medical Oncology (ASCO).

FDA Accepts Supplemental Biologics License Applications for Pembrolizumab

Peter Hofland, Ph.D -
123Page 1 of 3

LATEST

© 2020 Sunvalley Communication, LLC. All Rights Reserved.